Evidence map›Paper›PMID 22778398›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence.

David J Elzi, Yanlai Lai, Meihua Song, Kevin Hakala, Susan T Weintraub, Yuzuru Shiio

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 160 citations in OpenAlex.

  1. Pooled it
  2. Age-associated Autoimmunity Driven by T cell Immunosenescence.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Senescence-Associated Alterations in Matrisome of Mesenchymal Stem Cells.International journal of molecular sciences · 2024
    Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

David J ElziGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Yanlai Lai
Meihua Song
Kevin Hakala
Susan T Weintraub
Yuzuru Shiio
The University of Texas Health Science Center at San Antonio · USCancer Research Institute of the Slovak Academy of Sciences · SK

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
Analysis of the VHL-HIF hydroxylase pathwayR01CA125020 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SHIIO, YUZURU · 2007 to 2011
$1.1M
Secretome Proteomics for VHL Tumor Biomarker DiscoveryR21CA137568 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SHIIO, YUZURU · 2009 to 2010
$327k
Quantitative Proteomic Analysis of the Secretory Pattern of Senescent CellsR21AG029587 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SHIIO, YUZURU · 2007 to 2008
$296k
NCI NIH HHS CA054174NCI NIH HHS CA125020NCI NIH HHS CA137568NCI NIH HHS P30 CA054174NCI NIH HHS R01 CA125020NCI NIH HHS R21 CA137568NIA NIH HHS AG029587NIA NIH HHS R21 AG029587
6 · The paper itself

Abstract

Cellular senescence is widely believed to play a key role in tumor suppression, but the molecular pathways that regulate senescence are only incompletely understood. By using a secretome proteomics approach, we identified insulin-like growth factor binding protein 3 (IGFBP3) as a secreted mediator of breast cancer senescence upon chemotherapeutic drug treatment. The senescence-inducing activity of IGFBP3 is inhibited by tissue-type plasminogen activator-mediated proteolysis, which is counteracted by plasminogen activator inhibitor 1 (PAI-1), another secreted mediator of senescence. We demonstrate that IGFBP3 is a critical downstream target of PAI-1-induced senescence. These results suggest a role for an extracellular cascade of secreted proteins in the regulation of cellular senescence.

Indexed as

Analysis of Variancebeta-GalactosidaseCell Line, TumorCellular SenescenceCulture MediaDNA PrimersDoxorubicinEnzyme-Linked Immunosorbent AssayFluorescent Antibody TechniqueHumansImmunoblottingImmunohistochemistryInsulin-Like Growth Factor Binding Protein 3NeoplasmsPlasminogen Activator Inhibitor 1Proteolysisbeta-GalactosidaseCulture MediaDNA PrimersDoxorubicinIGFBP3 protein, humanInsulin-Like Growth Factor Binding Protein 3Plasminogen Activator Inhibitor 1RNA, Small InterferingSERPINE1 protein, humanTissue Plasminogen Activator

Identifiers

PMID22778398
PMCPMC3409757
OpenAlexW2074103997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.